Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Company Registration No. 04734476 (England and Wales) Charity Registration No. 1106712 (England and Wales)
Medical Screening Society
(a company limited by guarantee)
Trustees’ report and
unaudited financial statements for the year ended 31 March 2025
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Company information
| Trustees | Malcolm Law |
|---|---|
| Nicholas Wald | |
| Secretary | Nicholas Wald |
| Company number | 04734476 |
| Charity number | 1106712 |
| Registered office | 29/30 Newbury Street |
| London | |
| EC1A 7HZ | |
| Bankers | National Westminster Bank Plc |
| 45 Tottenham Court Road | |
| London | |
| W1T 2EA |
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Contents
| Page | |
|---|---|
| Trustees’ report | 1 - 2 |
| Statement of financial activities | 3 |
| Balance sheet | 4 |
| Notes to the financial statements | 5 - 6 |
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Trustees’ report For the year ended 31 March 2025
Medical Screening Society (a company limited by guarantee)
The Trustees (who are also the directors of Medical Screening Society for the purposes of Company Law) present their report and financial statements for the year ended 31 March 2025.
Structure, governance and management
The Medical Screening Society is a Company, limited by Guarantee, which is governed by its Memorandum and Articles of Association. Charitable status was granted on 11 November 2004. The Trustees who served during the year are listed on the company information page. The company’s Articles of Association allows for a minimum of two and a maximum of ten Trustees. The existing Trustees may from time to time and at any time appoint any member of the Charity as a Trustee, either to fill a casual vacancy or by way of addition to the existing Trustees, provided that the prescribed maximum is not exceeded. Any member so appointed shall retain their office only until the next Annual General Meeting, but they shall then be eligible for re-election. No person who is not a member of the Charity shall in any circumstances be eligible to hold office as a Trustee.
Objectives and activities
The objects of the charity, as laid out in its Memorandum of Association are:
“to promote the health of the public and to advance the education of the public in the subject of medical screening by:
-
(a) research into medical screening and publication of such research to the public; and (b) providing a forum for those interested in medical screening.”
-
The objects were fulfilled in the year by:
-
(a) the quarterly publication of the Journal of Medical Screening; and
-
(b) maintaining the publicly accessible website of the Charity, which includes scientific papers on various aspects of screening.
The trustees confirm that they have referred to the Charity Commission’s guidance on public benefit when reviewing the Trust’s aims and objectives and in planning future activities.
Achievements and performance
-
(i) The Journal of Medical Screening continues to remain the leading specialist journal on the subject in the world. The Journal website offers free public access to all papers more than two years old and some articles from the date of publication. There is free access to all supplementary material for historic and current publications as well as Editorials. The Editorial Board Members have been active. The service provided by the two Editors Professor Allan Hackshaw and Professor Stephen Duffy has been of great value. They support the Editor-in-Chief. In the year covered by this report the Journal has received papers on primary prevention where this is more in the public health interest than screening. The Charity continues successfully.
-
(ii) The Charity website has been maintained with presentations by members of the Charity being uploaded and made accessible to the public, with advice on specific screening topics. An improved interactive Risk-Screening Converter has been added to the Charity’s website that is available for public use and has been used in this way. Their website hosts a report on a workshop that concluded that infection with a virus, Epstein Barr virus (EBV) is an important cause of multiple sclerosis. The report has stimulated research into making a vaccine to prevent EBV infection and, as a result, multiple sclerosis.
1
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee) Trustees’ report (continued) For the year ended 31 March 2025
Financial review
As indicated on the balance sheet, the Charity held unrestricted funds of £76,930 at 31 March 2025 (2024: £65,058), at which date they were considered to be at a sufficient level of reserves to meet the future working capital needs of the Charity.
Statement of trustees’ responsibilities
The trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources, including the income and expenditure, of the Charity for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP (FRS 102);
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. The trustees are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
This report is prepared in accordance with the small company regime (Section 419(2)) of the Companies Act 2006.
On behalf of the board
cor pan Wald Nicholas Wald Trustee
16 October 2025 Date: .............................................
2
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Statement of financial activities (incorporating income and expenditure account) For the year ended 31 March 2025
| Unrestricted | Unrestricted | ||
|---|---|---|---|
| and Total Funds | and Total Funds | ||
| 2025 | 2024 | ||
| Income | Notes | £ | £ |
| Income from charitable activities | |||
| Membership income | 3,371 | 1,243 | |
| Journal of Medical Screening | 12,725 | 14,276 | |
| Total income | 16,096 | 15,519 | |
| Expenditure | |||
| Expenditure on charitable activities | |||
| Journal of Medical Screening | 3,026 | 772 | |
| Website and promotions costs | 468 | 365 | |
| Staff and office consumables costs | 80 | 191 | |
| Governance costs | 650 | 1,516 | |
| Total expenditure | 2 | 4,224 | 2,844 |
| Net income/(expenditure) and net movement in | |||
| funds for the year | 11,872 | 12,675 | |
| Funds at 1 April 2024 | 65,058 | 52,383 | |
| Funds at 31 March 2025 | 76,930 | 65,058 |
The statement of financial activities contains all recognised gains and losses for the year.
The notes on pages 5 and 6 form part of these financial statements.
3
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Balance sheet As at 31 March 2025
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| Current assets | |||||
| Other debtors | 1,151 | 4,123 | |||
| Cash at bank and in hand | 89,159 | 62,320 | |||
| 90,310 | 64,443 | ||||
| Creditors: amounts falling due | |||||
| within one year | 4 | (13,380) | (1,385) | ||
| Total assets less current liabilities | 76,930 | 65,058 | |||
| Reserves | |||||
| Unrestricted funds | 76,930 | 65,058 | |||
| 76,930 | 65,058 |
The notes on pages 5 and 6 form part of these financial statements.
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
No members have required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 of the Companies Act.
The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and constitute the annual financial statements required by the Companies Act 2006 and are for circulation to members of the Company.
16 October 2025
Approved by the Board for issue on ……………………………
cor pan Wald Nicholas Wald Trustee
Company Registration No. 04734476
4
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Notes to the financial statements For the year ended 31 March 2025
1 Accounting policies
- 1.1
Accounting convention
The financial statements have been prepared under the historic cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts. They also comply with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The charity constitutes a public benefit entity as defined by FRS 102.
- 1.2
Going Concern
At the time of approving the financial statements, the trustees are of the view that there are no material uncertainties about the charity’s ability to continue as a going concern. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
- 1.3 Income
Income is recognised when the charity is legally entitled to the funds.
- 1.4 Expenditure
Expenditure is recognised on an accruals basis and allocated to the categories of charitable expenditure as they arise.
- 1.5 Fund accounting
All funds received by the charity are unrestricted and are applied at the discretion of the trustees within the general objects.
- 1.6 Critical accounting judgements
In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. No key judgements or assumptions have been made by the Trustees in the preparation of the financial statements.
2
Expenditure
No remuneration or expenses were paid to the Trustees in this or the preceding year.
The charity has no directly employed staff. Day to day administration is carried out by the Trustees. The Trustees therefore consider there to be no remuneration paid to key management personnel.
3 Taxation
As a registered charity the company is not liable for any tax on its wholly charitable activities.
5
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Notes to the financial statements For the year ended 31 March 2025
4 Creditors: amounts falling due within one year
| Trade creditors Accruals Other creditors |
2025 2024 £ £ 3,700 - 1,326 1,385 8,354 - 13,380 1,385 |
|---|---|
5 Legal status
The Charity is a company limited by Guarantee and has no share capital. The liability of each Trustee in the event of a winding up is limited to £1. At 31 March 2025 the total of such liability was £2.
6 Related party transactions
There were no related party transactions requiring disclosure in the period.
6
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Company Registration No. 04734476 (England and Wales) Charity Registration No. 1106712 (England and Wales)
Medical Screening Society
(a company limited by guarantee)
Trustees’ report and
unaudited financial statements for the year ended 31 March 2025
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Company information
| Trustees | Malcolm Law |
|---|---|
| Nicholas Wald | |
| Secretary | Nicholas Wald |
| Company number | 04734476 |
| Charity number | 1106712 |
| Registered office | 29/30 Newbury Street |
| London | |
| EC1A 7HZ | |
| Bankers | National Westminster Bank Plc |
| 45 Tottenham Court Road | |
| London | |
| W1T 2EA |
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Contents
| Page | |
|---|---|
| Trustees’ report | 1 – 2 |
| Accountants' report | 3 |
| Statement of financial activities | 4 |
| Balance sheet | 5 |
| Notes to the financial statements | 6 - 7 |
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Trustees’ report For the year ended 31 March 2025
Medical Screening Society (a company limited by guarantee)
The Trustees (who are also the directors of Medical Screening Society for the purposes of Company Law) present their report and financial statements for the year ended 31 March 2025.
Structure, governance and management
The Medical Screening Society is a Company, limited by Guarantee, which is governed by its Memorandum and Articles of Association. Charitable status was granted on 11 November 2004. The Trustees who served during the year are listed on the company information page. The company’s Articles of Association allows for a minimum of two and a maximum of ten Trustees. The existing Trustees may from time to time and at any time appoint any member of the Charity as a Trustee, either to fill a casual vacancy or by way of addition to the existing Trustees, provided that the prescribed maximum is not exceeded. Any member so appointed shall retain their office only until the next Annual General Meeting, but they shall then be eligible for re-election. No person who is not a member of the Charity shall in any circumstances be eligible to hold office as a Trustee.
Objectives and activities
The objects of the charity, as laid out in its Memorandum of Association are:
“to promote the health of the public and to advance the education of the public in the subject of medical screening by:
-
(a) research into medical screening and publication of such research to the public; and (b) providing a forum for those interested in medical screening.”
-
The objects were fulfilled in the year by:
-
(a) the quarterly publication of the Journal of Medical Screening; and
-
(b) maintaining the publicly accessible website of the Charity, which includes scientific papers on various aspects of screening.
The trustees confirm that they have referred to the Charity Commission’s guidance on public benefit when reviewing the Trust’s aims and objectives and in planning future activities.
Achievements and performance
-
(i) The Journal of Medical Screening continues to remain the leading specialist journal on the subject in the world. The Journal website offers free public access to all papers more than two years old and some articles from the date of publication. There is free access to all supplementary material for historic and current publications as well as Editorials. The Editorial Board Members have been active. The service provided by the two Editors Professor Allan Hackshaw and Professor Stephen Duffy has been of great value. They support the Editor-in-Chief. In the year covered by this report the Journal has received papers on primary prevention where this is more in the public health interest than screening. The Charity continues successfully.
-
(ii) The Charity website has been maintained with presentations by members of the Charity being uploaded and made accessible to the public, with advice on specific screening topics. An improved interactive Risk-Screening Converter has been added to the Charity’s website that is available for public use and has been used in this way. Their website hosts a report on a workshop that concluded that infection with a virus, Epstein Barr virus (EBV) is an important cause of multiple sclerosis. The report has stimulated research into making a vaccine to prevent EBV infection and, as a result, multiple sclerosis.
1
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee) Trustees’ report (continued) For the year ended 31 March 2025
Financial review
As indicated on the balance sheet, the Charity held unrestricted funds of £76,930 at 31 March 2025 (2024: £65,058), at which date they were considered to be at a sufficient level of reserves to meet the future working capital needs of the Charity.
Statement of trustees’ responsibilities
The trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources, including the income and expenditure, of the Charity for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP (FRS 102);
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. The trustees are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
This report is prepared in accordance with the small company regime (Section 419(2)) of the Companies Act 2006.
On behalf of the board
cor pan Wald
Nicholas Wald Trustee
16 October 2025 Date: .............................................
2
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Accountants' report to the Board of Trustees on the preparation of the unaudited statutory financial statements of Medical Screening Society for the year ended 31 March 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Medical Screening Society for the year ended 31 March 2025 set out on pages 4 to 7 from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance.
This report is made solely to the Board of Trustees of Medical Screening Society, as a body, in accordance with the terms of our engagement letter dated 21 November 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Medical Screening Society and state those matters that we have agreed to state to the Board of Trustees of Medical Screening Society, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medical Screening Society and its Board of Trustees as a body, for our work or for this report.
It is your duty to ensure that Medical Screening Society has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Medical Screening Society. You consider that Medical Screening Society is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Medical Screening Society. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Saffery LLP
Date: ............................................. 71 Queen Victoria Street London EC4V 4BE
3
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Statement of financial activities (incorporating income and expenditure account) For the year ended 31 March 2025
| Unrestricted | Unrestricted | ||
|---|---|---|---|
| and Total Funds | and Total Funds | ||
| 2025 | 2024 | ||
| Income | Notes | £ | £ |
| Income from charitable activities | |||
| Membership income | 3,371 | 1,243 | |
| Journal of Medical Screening | 12,725 | 14,276 | |
| Total income | 16,096 | 15,519 | |
| Expenditure | |||
| Expenditure on charitable activities | |||
| Journal of Medical Screening | 3,026 | 772 | |
| Website and promotions costs | 468 | 365 | |
| Staff and office consumables costs | 80 | 191 | |
| Governance costs | 650 | 1,516 | |
| Total expenditure | 2 | 4,224 | 2,844 |
| Net income/(expenditure) and net movement in | |||
| funds for the year | 11,872 | 12,675 | |
| Funds at 1 April 2024 | 65,058 | 52,383 | |
| Funds at 31 March 2025 | 76,930 | 65,058 |
The statement of financial activities contains all recognised gains and losses for the year.
The notes on pages 6 and 7 form part of these financial statements.
4
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Balance sheet As at 31 March 2025
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| Current assets | |||||
| Other debtors | 1,151 | 4,123 | |||
| Cash at bank and in hand | 89,159 | 62,320 | |||
| 90,310 | 64,443 | ||||
| Creditors: amounts falling due | |||||
| within one year | 4 | (13,380) | (1,385) | ||
| Total assets less current liabilities | 76,930 | 65,058 | |||
| Reserves | |||||
| Unrestricted funds | 76,930 | 65,058 | |||
| 76,930 | 65,058 |
The notes on pages 6 and 7 form part of these financial statements.
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
No members have required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 of the Companies Act.
The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and constitute the annual financial statements required by the Companies Act 2006 and are for circulation to members of the Company.
16 October 2025
Approved by the Board for issue on …………………………..
cor pan Wald Nicholas Wald Trustee
Company Registration No. 04734476
5
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Notes to the financial statements For the year ended 31 March 2025
1 Accounting policies
- 1.1
Accounting convention
The financial statements have been prepared under the historic cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts. They also comply with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The charity constitutes a public benefit entity as defined by FRS 102.
- 1.2
Going Concern
At the time of approving the financial statements, the trustees are of the view that there are no material uncertainties about the charity’s ability to continue as a going concern. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
- 1.3 Income
Income is recognised when the charity is legally entitled to the funds.
- 1.4 Expenditure
Expenditure is recognised on an accruals basis and allocated to the categories of charitable expenditure as they arise.
- 1.5 Fund accounting
All funds received by the charity are unrestricted and are applied at the discretion of the trustees within the general objects.
- 1.6 Critical accounting judgements
In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. No key judgements or assumptions have been made by the Trustees in the preparation of the financial statements.
2
Expenditure
No remuneration or expenses were paid to the Trustees in this or the preceding year.
The charity has no directly employed staff. Day to day administration is carried out by the Trustees. The Trustees therefore consider there to be no remuneration paid to key management personnel.
3 Taxation
As a registered charity the company is not liable for any tax on its wholly charitable activities.
6
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Notes to the financial statements For the year ended 31 March 2025
4 Creditors: amounts falling due within one year
| Trade creditors Accruals Other creditors |
2025 2024 £ £ 3,700 - 1,326 1,385 8,354 - 13,380 1,385 |
|---|---|
5 Legal status
The Charity is a company limited by Guarantee and has no share capital. The liability of each Trustee in the event of a winding up is limited to £1. At 31 March 2025 the total of such liability was £2.
6 Related party transactions
There were no related party transactions requiring disclosure in the period.
7
Docusign Envelope ID: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41
Medical Screening Society (a company limited by guarantee)
Detailed trading and profit and loss account For the year ended 31 March 2025
| Turnover Membership Journal of Medical Screening Cost of sales Journal of Medical Screening Gross profit Administrative expenses Website Staff and office consumables costs Consultancy fees Accountancy fees PayPal and bank charges Foreign exchange gain/loss Operating profit/(loss) |
2025 £ £ 3,371 12,725 16,096 3,026 13,070 468 80 0 613 32 5 1,198 11,872 |
2024 £ £ 1,243 14,276 15,519 772 14,747 365 191 900 613 3 0 2,072 12,675 |
2024 £ £ 1,243 14,276 15,519 772 14,747 365 191 900 613 3 0 2,072 12,675 |
|---|---|---|---|
| 15,519 772 |
|||
| 14,747 2,072 |
|||
| 12,675 |
This page does not form part of the statutory financial statements
8
Certificate Of Completion
Envelope Id: BA1554AD-5C4A-4834-8C63-DBC8C0AA1C41 Subject: Medical Screening Society - Accounts Year Ended 31 March 2025 Source Envelope: Document Pages: 20 Signatures: 4 Certificate Pages: 4 Initials: 0 AutoNav: Enabled EnvelopeId Stamping: Enabled Time Zone: (UTC) Dublin, Edinburgh, Lisbon, London
Status: Completed
Envelope Originator: Silvia Stasova 71 Queen Victoria Street London, London EC4V 4BE Silvia.Stasova@saffery.com IP Address: 85.115.53.202
Record Tracking
Status: Original Holder: Silvia Stasova 15-Oct-2025 | 09:47 Silvia.Stasova@saffery.com
Location: DocuSign
Signer Events Signature Timestamp Nicholas John Wald Sent: 15-Oct-2025 | 09:54 waldnicholas@gmail.com Viewed: 15-Oct-2025 | 10:05 Security Level: Email, Account Authentication Signed: 16-Oct-2025 | 14:10 (None) Signature Adoption: Pre-selected Style Using IP Address: 81.174.173.59
Electronic Record and Signature Disclosure:
Accepted: 21-Mar-2025 | 13:51 ID: 6fc74e5d-243f-4482-825d-377c9e9b7dce Company Name: Saffery
| In Person Signer Events | Signature | Timestamp |
|---|---|---|
| Editor Delivery Events | Status | Timestamp |
| Agent Delivery Events | Status | Timestamp |
| Intermediary Delivery Events | Status | Timestamp |
| Certified Delivery Events | Status | Timestamp |
| Carbon Copy Events | Status | Timestamp |
| Witness Events | Signature | Timestamp |
| Notary Events | Signature | Timestamp |
| Envelope Summary Events | Status | Timestamps |
| Envelope Sent | Hashed/Encrypted | 15-Oct-2025 |
| Certified Delivered | Security Checked | 15-Oct-2025 |
| Signing Complete | Security Checked | 16-Oct-2025 |
| Completed | Security Checked | 16-Oct-2025 |
| Payment Events | Status | Timestamps |
| Electronic Record and Signature Disclosure | Electronic Record and Signature Disclosure |
Electronic Record and Signature Disclosure created on: 17-Apr-2024 | 11:21 Parties agreed to: Nicholas John Wald
ELECTRONIC RECORD AND SIGNATURE DISCLOSURE
From time to time, Saffery (we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through the DocuSign system. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to this Electronic Record and Signature Disclosure (ERSD), please confirm your agreement by selecting the check-box next to ‘I agree to use electronic records and signatures’ before clicking ‘CONTINUE’ within the DocuSign system.
Getting paper copies
At any time, you may request from us a paper copy of any record provided or made available electronically to you by us. You will have the ability to download and print documents we send to you through the DocuSign system during and immediately after the signing session and, if you elect to create a DocuSign account, you may access the documents for a limited period of time (usually 30 days) after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following the procedure described below.
Withdrawing your consent
If you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described below.
Consequences of changing your mind
If you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices or disclosures. Further, you will no longer be able to use the DocuSign system to receive required notices and consents electronically from us or to sign electronically documents from us.
All notices and disclosures will be sent to you electronically
Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through the DocuSign system all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us.
How to contact Saffery:
You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows:
To contact us by email send messages to: julie.berry@saffery.com
To advise Saffery of your new email address
To let us know of a change in your email address where we should send notices and disclosures electronically to you, you must send an email message to us at julie.berry@saffery.com and in the body of such request you must state: your previous email address, your new email address. We do not require any other information from you to change your email address.
If you created a DocuSign account, you may update it with your new email address through your account preferences.
To request paper copies from Saffery
To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an email to julie.berry@saffery.com and in the body of such request you must state your email address, full name, mailing address, and telephone number. We will bill you for any fees at that time, if any.
To withdraw your consent with Saffery
To inform us that you no longer wish to receive future notices and disclosures in electronic format you may:
i. decline to sign a document from within your signing session, and on the subsequent page, select the check-box indicating you wish to withdraw your consent, or you may;
ii. send us an email to julie.berry@saffery.com and in the body of such request you must state your email, full name, mailing address, and telephone number. We do not need any other information from you to withdraw consent.. The consequences of your withdrawing consent for online documents will be that transactions may take a longer time to process..
Required hardware and software
The minimum system requirements for using the DocuSign system may change over time. The - - current system requirements are found here: https://support.docusign.com/guides/signer guide signing-system-requirements.
Acknowledging your access and consent to receive and sign documents electronically
To confirm to us that you can access this information electronically, which will be similar to other electronic notices and disclosures that we will provide to you, please confirm that you have read this ERSD, and (i) that you are able to print on paper or electronically save this ERSD for your future reference and access; or (ii) that you are able to email this ERSD to an email address where you will be able to print on paper or save it for your future reference and access. Further, if you consent to receiving notices and disclosures exclusively in electronic format as described herein, then select the check-box next to ‘I agree to use electronic records and signatures’ before clicking ‘CONTINUE’ within the DocuSign system.
By selecting the check-box next to ‘I agree to use electronic records and signatures’, you confirm that:
-
You can access and read this Electronic Record and Signature Disclosure; and
-
You can print on paper this Electronic Record and Signature Disclosure, or save or send this Electronic Record and Disclosure to a location where you can print it, for future reference and access; and
-
Until or unless you notify Saffery as described above, you consent to receive exclusively through electronic means all notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you by Saffery during the course of your relationship with Saffery.